The MYH7B gene is associated with a rare form of heart disease known as left ventricular noncompaction cardiomyopathy (LVNC), which is characterized by the failure of the heart muscle to fully develop, resulting in a spongy and noncompacted appearance of the left ventricle. This condition can lead to heart failure, arrhythmias, and other cardiovascular complications. Genetic testing for mutations in the MYH7B gene can be crucial for diagnosing LVNC, understanding its progression, and managing treatment options for affected individuals.
At DNA Labs UAE, a specialized genetic test is available for individuals suspected of having or at risk for MYH7B-related LVNC. This test specifically looks for mutations in the MYH7B gene that are known to contribute to the development of this cardiomyopathy. The genetic test is a valuable tool for cardiologists and genetic counselors in making accurate diagnoses, guiding treatment plans, and providing genetic counseling for families affected by this condition.
The cost of the MYH7B genetic test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab for the presence of specific genetic mutations in the MYH7B gene. Results from the test can help in the early detection of LVNC, potentially improving outcomes through timely interventions. It is also beneficial for at-risk family members to understand their risk of developing the condition and make informed decisions about their health.
The PHOX2B gene plays a critical role in the development of the nervous system, and mutations in this gene are known to cause Congenital Central Hypoventilation Syndrome (CCHS), a rare disorder affecting respiratory control, with or without Hirschsprung disease, which impacts the bowel. The genetic test for identifying mutations in the PHOX2B gene is crucial for diagnosing individuals suspected of having CCHS, potentially with Hirschsprung disease.
This test, available at DNA Labs UAE, is priced at 4400 AED. It involves analyzing the patient's DNA to detect abnormalities in the PHOX2B gene that are indicative of the syndrome. Early detection through this genetic testing is vital for the management and treatment of the condition, allowing for tailored care plans that address the unique needs of each affected individual. Given the complexity of the syndromes associated with PHOX2B mutations, this test is an invaluable tool for healthcare providers and families seeking answers to respiratory and gastrointestinal symptoms present from a young age.
The ASCL1 Gene Central Hypoventilation Syndrome Congenital Genetic Test is a critical diagnostic tool available at DNA Labs UAE, aimed at identifying mutations in the ASCL1 gene, which are associated with Congenital Central Hypoventilation Syndrome (CCHS). CCHS is a rare genetic disorder that affects the autonomic control of breathing, causing individuals to hypoventilate, particularly during sleep, leading to a deficiency in oxygen and an excess of carbon dioxide in the blood. Early diagnosis and management are crucial for individuals with CCHS to lead a normal life.
The test, priced at 4400 AED, involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed for specific mutations in the ASCL1 gene. This gene plays a significant role in the development of the nervous system, including the neural crest cells, which are essential for the formation of the autonomic nervous system controlling involuntary functions like breathing.
By opting for this genetic test at DNA Labs UAE, individuals at risk or families with a history of CCHS can gain invaluable insights into their genetic status. This information not only aids in the confirmation of a CCHS diagnosis but also helps in the planning of appropriate management strategies and support for affected individuals, ensuring they receive the necessary care and interventions to lead healthier lives.
The PRKD1 Gene Congenital Heart Defects and Ectodermal Dysplasia Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the PRKD1 gene, which have been associated with congenital heart defects and ectodermal dysplasia. This comprehensive test is crucial for individuals with a family history or symptoms related to these conditions, as it aids in the early detection and management of these disorders. Priced at 4400 AED, the test involves analyzing the patient's DNA to pinpoint any genetic variations that could lead to the development of congenital heart issues and abnormalities in the development of the skin, hair, nails, or teeth, which are characteristic of ectodermal dysplasia. By opting for this test, patients and their families can gain valuable insights into their genetic makeup, enabling informed decisions about their health and treatment options.
The GATA5 Gene Congenital Heart Defects Multiple Types Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the GATA5 gene, which are associated with a variety of congenital heart defects (CHDs). These heart defects can range from mild to severe conditions that are present at birth and can affect the structure of a baby's heart and the way it works. The GATA5 gene plays a critical role in the development of the heart and its proper function, and mutations in this gene can lead to a spectrum of cardiac anomalies that may impact an individual's health and quality of life.
This test is particularly valuable for families with a history of congenital heart defects or for newborns who have been diagnosed with or are showing symptoms of heart abnormalities. Early detection through genetic testing can provide essential information for the management, treatment, and potential prevention of complications associated with these heart defects.
The test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for the presence of mutations in the GATA5 gene.
The cost of the GATA5 Gene Congenital Heart Defects Multiple Types Genetic Test is 4400 AED. While the price may seem significant, the invaluable insights gained from this test can guide healthcare providers in making informed decisions regarding the care and treatment of individuals with congenital heart defects, ultimately contributing to improved health outcomes and quality of life.
The TAB2 gene plays a crucial role in the development of the heart during the fetal stage. Mutations in this gene can lead to multiple types of congenital heart defects, which are structural problems with the heart present from birth. These defects can vary widely in severity, from minor issues that may resolve on their own to serious conditions that require immediate medical intervention.
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the TAB2 gene. This test is crucial for early detection of potential congenital heart defects, allowing for prompt medical intervention and management of the condition. The test involves analyzing a sample of the patient's DNA to look for specific mutations in the TAB2 gene that are known to be associated with congenital heart defects.
The cost of the TAB2 gene congenital heart defects multiple types genetic test at DNA Labs UAE is 4400 AED. The test is conducted in a state-of-the-art laboratory by experienced geneticists and technicians. Results from the test can provide valuable information for families and healthcare providers, guiding decisions about treatment and care for individuals who may be at risk for these heart defects. Early detection through genetic testing can significantly improve outcomes for those affected by congenital heart defects linked to TAB2 gene mutations.
The MMP3 Gene Coronary Heart Disease Susceptibility to Type 6 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to assess an individual's genetic predisposition to developing Coronary Heart Disease (CHD) Type 6. This test focuses on analyzing the MMP3 gene, which plays a critical role in the body's metabolic pathways and has been linked to the development and progression of coronary heart diseases. By examining specific markers and variations within the MMP3 gene, this test can help identify individuals at an increased risk, allowing for early intervention and personalized treatment plans.
The cost of the MMP3 Gene Coronary Heart Disease Susceptibility to Type 6 Genetic Test is 4400 AED. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test offers a valuable resource for those seeking to understand their genetic risk factors for CHD and take proactive steps towards managing their heart health.
The CR1 gene, also known as Complement Receptor 1, plays a crucial role in the immune system by mediating the clearance of immune complexes and modulating complement activation. CR1 deficiency is a rare genetic condition that can lead to an increased susceptibility to infections, autoimmune disorders, and certain types of hemolytic anemia, due to the impaired ability of the immune system to clear complexes and properly regulate complement activation.
A genetic test for CR1 deficiency can provide valuable information for individuals who may be at risk of this condition, either due to familial history or symptoms suggestive of complement system disorders. This test involves analyzing the DNA to identify mutations in the CR1 gene that could lead to reduced function or expression of the CR1 protein.
In the United Arab Emirates, DNA Labs UAE offers a comprehensive genetic test for CR1 deficiency. The cost of the test is 4400 AED. This test is performed in a state-of-the-art laboratory facility, where experienced professionals use advanced genetic sequencing technologies to ensure accurate and reliable results. Upon completion of the test, individuals receive a detailed report that can be used to guide further medical consultation and potential treatment options. It is an essential tool for those seeking to understand their genetic predisposition to CR1-related conditions and to take proactive steps in managing their health.
The LAMP2 gene plays a critical role in the human body, encoding the lysosome-associated membrane protein 2. Mutations in this gene are responsible for Danon disease, a rare genetic disorder characterized by cardiomyopathy, muscle weakness, and intellectual disability. To diagnose this condition accurately and facilitate early intervention, genetic testing is crucial.
DNA Labs UAE offers a specialized genetic test targeting the LAMP2 gene to confirm the presence of mutations associated with Danon disease. This test is a vital tool for individuals exhibiting symptoms of the disorder or those with a family history of Danon disease, enabling precise diagnosis and guiding treatment plans.
The cost of the LAMP2 gene Danon disease genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect mutations in the LAMP2 gene, offering peace of mind and crucial information for affected individuals and their families.
The ZFPM2 gene, also known as FOXC2 (Forkhead Box C2), plays a crucial role in the development of the diaphragm, a major muscle involved in breathing. Mutations in the ZFPM2 gene have been linked to Diaphragmatic Hernia type 3, a congenital condition characterized by the abnormal development of the diaphragm, which can lead to life-threatening respiratory difficulties in newborns.
DNA Labs UAE offers a specialized genetic test designed to detect mutations in the ZFPM2 gene associated with Diaphragmatic Hernia type 3. This test is crucial for families with a history of the condition, as it can help in early diagnosis and management of the disease. Early intervention is key in managing the symptoms and improving the quality of life for affected individuals.
The test is conducted using a sample of the patient's blood or saliva, employing advanced genetic sequencing techniques to accurately identify any mutations in the ZFPM2 gene. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to perform this specialized genetic analysis.
By choosing DNA Labs UAE for the ZFPM2 gene test, patients and their families can expect reliable results, professional confidentiality, and the support needed to understand and manage the implications of the test outcomes. This test is a vital tool in the early detection and treatment planning for Diaphragmatic Hernia type 3, offering hope and guidance for affected families.
